MNX internals
| ||||||||||||||||||||||||||||
| Parent-child relations graph |
|
|||||||||||||||||||||||||||
| Identifier | Description |
|---|---|
CHEBI:95341 chebi:95341 XUZMWHLSFXCVMG-UHFFFAOYSA-N | baricitinib 1-(ethylsulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]-3-azetidineacetonitrile 2-(3-(4-(3H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetonitrile INCB 028050 INCB-028050 INCB028050 LY 3009104 LY-3009104 LY3009104 Olumiant baricitinibum {1-(ethylsulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]azetidin-3-yl}acetonitrile |
kegg.drug:D10308 keggD:D10308 XUZMWHLSFXCVMG-UHFFFAOYSA-N | Baricitinib (JAN/USAN/INN) Olumiant (TN) |
| hmdb:HMDB0248873 XUZMWHLSFXCVMG-UHFFFAOYSA-N | Baricitinib 2-[1-(Ethanesulphonyl)-3-(4-{1h-pyrrolo[2,3-D]pyrimidin-4-yl}-1H-pyrazol-1-yl)azetidin-3-yl]acetonitrile 2-[1-(ethanesulfonyl)-3-(4-{7H-pyrrolo[2,3-d]pyrimidin-4-yl}-1H-pyrazol-1-yl)azetidin-3-yl]acetonitrile 2-[1-(ethanesulfonyl)-3-(4-{7H-pyrrolo[2,3-d]pyrimidin-4-yl}pyrazol-1-yl)azetidin-3-yl]acetonitrile INCB-28050ly3009104 INCB028050 Olumiant |
keggD:M_D10308 | secondary/obsolete/fantasy identifier |